Genetic and functional characterization of the cephalosporinases produced by 65 clonally unrelated clinical Escherichia coli isolates revealed genetic diversity of the ampC genes and showed that Gln287, Cys287, Pro296, Leu298, and Phe350 substitutions were involved in extension of the hydrolysis spectrum to include ceftazidime and cefepime.
analyses were performed with PAUP version 3.1.1 and software available at the internet websites www.ncbi.nlm.nih.gov and http://www.ebi.ac.uk/clustalw/. It revealed that ampC genes of E. coli may be divided into several clusters (Fig. 1 ). Since the species E. coli is divided into four main phylogroups (A, B1, B2, and D) (4), a PCR-based phylotyping analysis was applied to the 65 strains as previously described (4) . It revealed that the ampC clusters described above are related to phylogroups A and B1, B2, and D (Fig. 1 ). ESAC-producing strains E. coli EC13 to E. coli EC19 and E. coli KL belonged to phylogroup A or B1. This common origin can be attributed to the high prevalence of E. coli strains of these phylogroups in the digestive flora (4) .
Sequence analysis of the ampC genes of E. coli isolates EC13 to EC19 revealed mutations at position Ϫ42 or Ϫ32 or insertion of 1 bp between positions Ϫ15 and Ϫ16 in their own promoter region, which has been shown to account for AmpC expression at different levels (3, 15) . Plasmids of these AmpCproducing strains were extracted (11) and transferred onto a nylon membrane (20) . Hybridization of the membrane with a fluorescein-labeled probe that was made of the PCR product of the ampC-KL gene (12) failed to detect the ␤-lactamase gene in the plasmid DNA contents (data not shown). In addition, transformation experiments performed as previously described (12) , with plasmid DNA of AmpC-producing isolates, failed to obtain AmpC-producing transformants. All of these results argued for a chromosomal location of those ampC genes.
Amplification with primers Int-B1 (5Ј-TTTTGTATGGAAC CAGACC-3Ј) and Int-HN of ampC genes from E. coli isolates EC1, EC2, EC13 to EC20, EC23, EC24, EC27, EC30, EC31, EC34, EC37, EC41, EC43, EC55, EC58, E. coli KL, and E. coli 154297 gave PCR products of 1,120 bp containing only the coding regions without their own promoters. These PCR products were cloned into pCR-BluntII-Topo (Invitrogen), and the recombinant plasmids were subsequently transformed into E. coli strain TOP10 as described previously (12) , giving rise to clones harboring recombinant plasmids pEC1, pEC2, pEC13 to pEC20, pEC23, pEC24, pEC27, pEC30, pEC31, pEC34, pEC37, pEC41, pEC43, pEC55, pEC58, pKL, and pS4, respectively. In all of the recombinant plasmids, the orientation of the cloned insert was the same, with the ampC gene under the The ␤-lactamase activity against cephalothin and cefepime and the MICs of several ␤-lactams were determined for recombinant strains as described previously (18) . Results are shown in Tables 1  and 2 . Recombinant strains E. coli TOP10(pEC1) and E. coli TOP10(pEC2) had ␤-lactamase activities and MICs similar to those of strains E. coli TOP10(pEC20) to E. coli TOP10(pEC58).
Comparison of amino acid sequences (Table 3) , MICs (Table 2), and ␤-lactamase activities (Table 1) showed that the enhancement of the hydrolysis activity against ceftazidime and cefepime was related to Ser3Gln, Ser3Cys, His3Pro, Val3Leu, and Val3Phe substitutions at positions 287, 287, 296, 298, and 350, respectively ( Table 1 ). The effects of the S287N and V298L substitutions on the resistance levels and ␤-lactamase activities are greater than those related to the S287C, H296P, and V350F substitutions (Tables 1 to 3) . AmpC-EC13, AmpC-EC18, and AmpC-EC14, which have an S287N or V298L substitution, had reduced susceptibility to cefepime and cefpirome (MICs equal to 8 or 16 g/ml), whereas AmpC-EC15, AmpC-EC16, AmpC-EC17, AmpC-EC19, and AmpC-KL, which presented an S287C, H296P, or V350F substitution, did not confer resistance to cefepime, although the MICs for the strains producing these proteins were 30-to 60-fold higher than those for wild-type E. coli.
The region containing residues 287, 296, and 298 is located inside or in close proximity to helix H-10 (7, 12). This region is probably a hot spot where amino acid deletions leading to extension of the hydrolysis spectrum were already described in AmpC D from E. coli HKY28 (7), AmpC-HD from Serratia marcescens HD (13), and AmpC-CHE from Enterobacter cloacae MHN1 (1).
Interestingly, a V350F substitution is responsible for extended-spectrum hydrolysis in AmpC from E. coli belonging to phylogroup B1 but not in AmpC from E. coli belonging to phylogroup B2 (Table 2 and Fig. 1) , suggesting that other residues may contribute to modify the hydrolysis spectrum in combination with a Phe350 substitution.
This study indicates that isolation of ESAC-producing E. coli a One unit of ␤-lactamase activity is defined as 1 mol of cephalothin or cefepime hydrolyzed per min. The ␤-lactamase activities shown are geometric mean determinations for three independent cultures. The standard deviations were within 10%. Recombinant E. coli strains TOP10(pEC13) to TOP10(pEC19) and TOP10(pKL) produced ESAC ␤-lactamases, whereas TOP10(pEC1) and TOP10(pEC2) produced typical cephalosporinases. 
